Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bionid Forte is an oral nutritional supplement developed and marketed by Nidus Pharma, a specialty dermatology company. It is specifically formulated to support hair and nail health and is primarily indicated for the management of various forms of alopecia, such as telogen effluvium. The product is a high-potency combination of Biotin (Vitamin B7), Calcium Pantothenate (Vitamin B5), N-acetylcysteine, and essential trace minerals including Zinc, Selenium, Copper, and Manganese. Biotin acts as a critical cofactor for carboxylase enzymes involved in fatty acid synthesis and gluconeogenesis, which are essential for keratin production. N-acetylcysteine serves as a precursor to glutathione, providing antioxidant protection to hair follicles against oxidative stress. The mineral components function as enzymatic cofactors necessary for protein metabolism and cellular repair within the skin and its appendages.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bionid Forte.